세계의 감염증 분자진단 시장 보고서(2025년)

Infectious disease molecular diagnostics involves advanced laboratory methods used to detect and identify genetic material from pathogens like bacteria, viruses, fungi, or parasites in patient samples. These diagnostics facilitate rapid and precise diagnosis of infectious diseases, enabling timely treatment and effective disease management.

The primary product categories in infectious disease molecular diagnostics include kits and reagents, instruments, software, and services. Kits and reagents consist of pre-packaged chemical and biological components designed for specific laboratory tests or procedures, such as detecting, measuring, or amplifying genetic material, proteins, or pathogens. Key technologies employed in this area include polymerase chain reaction, in situ hybridization, isothermal nucleic acid amplification, chips and microarrays, mass spectrometry, transcription-mediated amplification, among others. These tools are applied to a variety of conditions, including respiratory diseases, tuberculosis, meningitis, gastrointestinal infections, human papillomavirus, sexually transmitted infections, sepsis, and drug-resistant diseases. End users include hospitals and clinical laboratories, diagnostic labs, pharmaceutical companies, and academic and research institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The infectious disease molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides infectious disease molecular diagnostics market statistics, including infectious disease molecular diagnostics global market size, regional shares, competitors with infectious disease molecular diagnostics market share, detailed infectious disease molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the infectious disease molecular diagnostics industry. The infectious disease molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The infectious disease molecular diagnostics market size has grown strongly in recent years. It will grow from $28.95 billion in 2024 to $30.46 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth during the historic period can be attributed to the increasing prevalence of infectious diseases, growing demand for early and accurate diagnosis, the rise in global outbreaks and pandemics, enhanced healthcare awareness and access, and increased investment in diagnostic research and technology.

The infectious disease molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $36.98 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth projected for the forecast period can be attributed to the increasing adoption of point-of-care testing, a stronger focus on personalized medicine, rising government support for infectious disease control, expanding healthcare infrastructure in emerging markets, and the growing prevalence of respiratory diseases. Key trends expected during this period include advancements in real-time polymerase chain reaction technology, enhanced integration of artificial intelligence in diagnostic platforms, development of multiplex testing panels, innovations in portable and home-based diagnostic kits, and progress in automating molecular diagnostic workflows.

The rising prevalence of infectious diseases is expected to drive growth in the infectious disease molecular diagnostics market going forward. Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, which can be transmitted directly or indirectly between people. The increase in infectious diseases is mainly due to globalization and higher travel rates, enabling pathogens to spread quickly across borders and turn localized outbreaks into global health crises. Molecular diagnostics for infectious diseases support disease management by providing rapid and accurate detection of pathogens at the genetic level, which aids early diagnosis, targeted treatment, and effective outbreak control. For example, according to the US Centers for Disease Control and Prevention, in 2022, the United States reported 8,331 tuberculosis (TB) cases, reflecting a 5.9% increase compared to 2021. Therefore, the growing prevalence of infectious diseases is fueling the expansion of the infectious disease molecular diagnostics market.

Leading companies in the infectious disease molecular diagnostics market are concentrating on developing innovative solutions such as real-time polymerase chain reaction (PCR) kits, which enable rapid, accurate, and high-throughput detection of infectious pathogens. Real-time PCR kits amplify and detect specific genetic material of pathogens simultaneously in real time, allowing for fast and precise identification of infectious diseases. For instance, in February 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences company, introduced Applied Biosystems TaqPath PCR kits for infectious disease detection in India. These kits offer fast, highly sensitive multiplex diagnostic solutions that perform real-time PCR detection of infectious disease targets through a complete workflow-from ribonucleic acid extraction to diagnostic report generation, typically within four hours. The kits include multiplexed assays targeting multiple pathogen genomic regions, internal process controls, and automated data interpretation, which reduces user error and improves reliability of results.

In May 2024, Bruker Corporation, a US-based scientific instrument and analytical technology company, acquired ELITechGroup for $0.94 billion. Through this acquisition, Bruker Corporation aims to enhance its expertise in infectious disease diagnostics by obtaining access to advanced sample-to-answer molecular diagnostic systems and an extensive portfolio of infectious disease assays that complement its existing products. ELITechGroup SAS is a France-based company specializing in infectious disease molecular diagnostics.

Major players in the infectious disease molecular diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel Ortho Corporation, Sysmex Corporation, Bio Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., and Sherlock Biosciences Inc.

North America was the largest region in the infectious disease molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in infectious disease molecular diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the infectious disease molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The infectious disease molecular diagnostics market consists of revenues earned by entities by providing services such as polymerase chain Reaction (PCR) testing, next-generation sequencing, isothermal nucleic acid amplification tests, point-of-care (POC) molecular testing, and viral load monitoring and resistance testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The infectious disease molecular diagnostics market also includes sales of nucleic acid extraction systems, isothermal amplification assays, multiplex diagnostic panels, molecular diagnostic reagents and consumables, and bloodborne pathogen detection kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Infectious Disease Molecular Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on infectious disease molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for infectious disease molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The infectious disease molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Kits And Reagents; Instruments; Software And Services
• 2) By Technology: Polymerase Chain Reaction; In Situ Hybridization; Isothermal Nucleic Acid Amplification Technology; Chips And Microarrays; Mass Spectrometry; Transcription Mediated Amplification; Other Technologies
• 3) By Application: Respiratory Diseases; Tuberculosis; Meningitis; Gastrointestinal Tract Infections; Human Papillomavirus; Sexually Transmitted Infections; Sepsis; Drug Resistance Diseases; Other Applications
• 4) By End-User: Hospitals And Clinical Laboratories; Diagnostic Laboratories; Pharmaceutical Companies; Academic And Research Institutes
• Subsegments:
• 1) By Kits And Reagents: Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits; Polymerase Chain Reaction Reagents; Isothermal Amplification Kits; Probe-Based Detection Reagents; Pathogen-Specific Assay Kits
• 2) By Instruments: Real-Time Polymerase Chain Reaction Systems; Isothermal Amplification Instruments; Automated Sample Preparation Systems; Next-Generation Sequencing Platforms; Microarray Analyzers
• 3) By Software And Services: Data Analysis And Interpretation Software; Laboratory Information Management Systems; Cloud-Based Infectious Disease Diagnostic Platforms; Instrument Integration And Workflow Management Tools; Bioinformatics Services
• Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Becton Dickinson and Company (BD); Agilent Technologies Inc.; Hologic Inc.; Illumina Inc.; Biomerieux S.A.; Quidel-Ortho Corporation; Sysmex Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; DiaSorin S.p.A.; Seegene Inc.; Oxford Nanopore Technologies plc; Biocartis NV; T2 Biosystems Inc.; Sherlock Biosciences Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Infectious Disease Molecular Diagnostics Market Characteristics

3. Infectious Disease Molecular Diagnostics Market Trends And Strategies

4. Infectious Disease Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Infectious Disease Molecular Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Infectious Disease Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Infectious Disease Molecular Diagnostics Market Growth Rate Analysis
• 5.4. Global Infectious Disease Molecular Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Infectious Disease Molecular Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Infectious Disease Molecular Diagnostics Total Addressable Market (TAM)

6. Infectious Disease Molecular Diagnostics Market Segmentation

• 6.1. Global Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kits And Reagents
• Instruments
• Software And Services
• 6.2. Global Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction
• In Situ Hybridization
• Isothermal Nucleic Acid Amplification Technology
• Chips And Microarrays
• Mass Spectrometry
• Transcription Mediated Amplification
• Other Technologies
• 6.3. Global Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Respiratory Diseases
• Tuberculosis
• Meningitis
• Gastrointestinal Tract Infections
• Human Papillomavirus
• Sexually Transmitted Infections
• Sepsis
• Drug Resistance Diseases
• Other Applications
• 6.4. Global Infectious Disease Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinical Laboratories
• Diagnostic Laboratories
• Pharmaceutical Companies
• Academic And Research Institutes
• 6.5. Global Infectious Disease Molecular Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits
• Polymerase Chain Reaction Reagents
• Isothermal Amplification Kits
• Probe-based Detection Reagents
• Pathogen-Specific Assay Kits
• 6.6. Global Infectious Disease Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Real-Time Polymerase Chain Reaction Systems
• Isothermal Amplification Instruments
• Automated Sample Preparation Systems
• Next-Generation Sequencing Platforms
• Microarray Analyzers
• 6.7. Global Infectious Disease Molecular Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Analysis And Interpretation Software
• Laboratory Information Management Systems
• Cloud-Based Infectious Disease Diagnostic Platforms
• Instrument Integration And Workflow Management Tools
• Bioinformatics Services

7. Infectious Disease Molecular Diagnostics Market Regional And Country Analysis

• 7.1. Global Infectious Disease Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Infectious Disease Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Infectious Disease Molecular Diagnostics Market

• 8.1. Asia-Pacific Infectious Disease Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Infectious Disease Molecular Diagnostics Market

• 9.1. China Infectious Disease Molecular Diagnostics Market Overview
• 9.2. China Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Infectious Disease Molecular Diagnostics Market

• 10.1. India Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Infectious Disease Molecular Diagnostics Market

• 11.1. Japan Infectious Disease Molecular Diagnostics Market Overview
• 11.2. Japan Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Infectious Disease Molecular Diagnostics Market

• 12.1. Australia Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Infectious Disease Molecular Diagnostics Market

• 13.1. Indonesia Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Infectious Disease Molecular Diagnostics Market

• 14.1. South Korea Infectious Disease Molecular Diagnostics Market Overview
• 14.2. South Korea Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Infectious Disease Molecular Diagnostics Market

• 15.1. Western Europe Infectious Disease Molecular Diagnostics Market Overview
• 15.2. Western Europe Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Infectious Disease Molecular Diagnostics Market

• 16.1. UK Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Infectious Disease Molecular Diagnostics Market

• 17.1. Germany Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Infectious Disease Molecular Diagnostics Market

• 18.1. France Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Infectious Disease Molecular Diagnostics Market

• 19.1. Italy Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Infectious Disease Molecular Diagnostics Market

• 20.1. Spain Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Infectious Disease Molecular Diagnostics Market

• 21.1. Eastern Europe Infectious Disease Molecular Diagnostics Market Overview
• 21.2. Eastern Europe Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Infectious Disease Molecular Diagnostics Market

• 22.1. Russia Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Infectious Disease Molecular Diagnostics Market

• 23.1. North America Infectious Disease Molecular Diagnostics Market Overview
• 23.2. North America Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Infectious Disease Molecular Diagnostics Market

• 24.1. USA Infectious Disease Molecular Diagnostics Market Overview
• 24.2. USA Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Infectious Disease Molecular Diagnostics Market

• 25.1. Canada Infectious Disease Molecular Diagnostics Market Overview
• 25.2. Canada Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Infectious Disease Molecular Diagnostics Market

• 26.1. South America Infectious Disease Molecular Diagnostics Market Overview
• 26.2. South America Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Infectious Disease Molecular Diagnostics Market

• 27.1. Brazil Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Infectious Disease Molecular Diagnostics Market

• 28.1. Middle East Infectious Disease Molecular Diagnostics Market Overview
• 28.2. Middle East Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Infectious Disease Molecular Diagnostics Market

• 29.1. Africa Infectious Disease Molecular Diagnostics Market Overview
• 29.2. Africa Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Infectious Disease Molecular Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Infectious Disease Molecular Diagnostics Market Competitive Landscape
• 30.2. Infectious Disease Molecular Diagnostics Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Infectious Disease Molecular Diagnostics Market Other Major And Innovative Companies

• 31.1. Becton Dickinson and Company (BD)
• 31.2. Agilent Technologies Inc.
• 31.3. Hologic Inc.
• 31.4. Illumina Inc.
• 31.5. Biomerieux S.A.
• 31.6. Quidel-Ortho Corporation
• 31.7. Sysmex Corporation
• 31.8. Bio-Rad Laboratories Inc.
• 31.9. QIAGEN N.V.
• 31.10. DiaSorin S.p.A.
• 31.11. Seegene Inc.
• 31.12. Oxford Nanopore Technologies plc
• 31.13. Biocartis NV
• 31.14. T2 Biosystems Inc.
• 31.15. Sherlock Biosciences Inc

32. Global Infectious Disease Molecular Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Infectious Disease Molecular Diagnostics Market

34. Recent Developments In The Infectious Disease Molecular Diagnostics Market

35. Infectious Disease Molecular Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Infectious Disease Molecular Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Infectious Disease Molecular Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Infectious Disease Molecular Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer